Abstract
Objective: to elaborate the methods of treatment for the patients with diabetic retinopathy (DR) by means of both conventional treatment (medical or surgical) and preparations with extracted fetal stem cells (FSCs) in suspensions containing stem cells of fetal liver, brain and fetal eye. Materials and methods: A comparative study was conducted on 15 patients with diabetic retinopathy including 7 women and 8 men aged from 27 to 61 years. All patients were administered conventional treatment, laser coagulation and, only over 6 months following the latter, FSCs suspensions containing cells separated from human embryonic tissues of fetal liver, brain and fetal eye were used for treatment of the patients under study. Results: Authors proved effectiveness and safety of treatment using FSCs in patients suffering from DR. Based on the study we recorded improvements of glycemic and lipids profile as well as overall ophthalmology status among the patients. Conclusion: FSCs use in complex treatment of patients with DR stabilizes disease compensation, can improve laboratory values and ophthalmology status.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.